Norges Bank Alkermes Plc. Transaction History

Norges Bank

  • $772 Billion
  • Q2 2025

A detailed history of Norges Bank transactions in Alkermes Plc. stock. As of the latest transaction made, Norges Bank holds 1,863,895 shares of ALKS stock, worth $51 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
1,863,895
Holding current value
$51 Million
% of portfolio
0.01%

Shares

51 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 13, 2025
BUY
$26.59 - $32.65 $49.6 Million - $60.9 Million
1,863,895 New
1,863,895 $53.3 Million
Q4 2024

Feb 12, 2025
BUY
$25.7 - $31.46 $50.7 Million - $62 Million
1,970,941 New
1,970,941 $56.7 Million
Q2 2024

Aug 14, 2024
BUY
$23.21 - $27.24 $49.4 Million - $58 Million
2,128,943 New
2,128,943 $51.3 Million
Q1 2024

May 14, 2025
BUY
$26.4 - $32.56 $54.4 Million - $67.1 Million
2,060,014 New
2,060,014 $55.8 Million
Q4 2023

Feb 09, 2024
BUY
$23.37 - $28.68 $46.8 Million - $57.4 Million
2,002,453 New
2,002,453 $55.5 Million
Q3 2023

Nov 13, 2024
BUY
$27.17 - $31.97 $45.1 Million - $53 Million
1,658,336 New
1,658,336 $46.4 Million
Q3 2023

Nov 13, 2023
SELL
$27.17 - $31.97 $42.2 Million - $49.6 Million
-1,552,485 Closed
0 $0
Q2 2023

Aug 14, 2024
SELL
$28.34 - $33.63 $16.5 Million - $19.6 Million
-581,386 Reduced 27.31%
1,547,557 $48.4 Million
Q2 2023

Aug 14, 2023
SELL
$28.34 - $33.63 $44.8 Million - $53.1 Million
-1,579,146 Closed
0 $0
Q1 2023

May 15, 2024
BUY
$25.31 - $29.02 $38.2 Million - $43.9 Million
1,511,084 New
1,511,084 $42.6 Million
Q4 2022

Feb 14, 2023
BUY
$21.94 - $26.24 $37.2 Million - $44.5 Million
1,697,574 New
1,697,574 $44.4 Million
Q3 2022

Nov 13, 2023
BUY
$22.0 - $31.87 $34.2 Million - $49.5 Million
1,552,485 New
1,552,485 $34.7 Million
Q2 2022

Aug 14, 2023
BUY
$26.4 - $30.54 $41.7 Million - $48.2 Million
1,579,146 New
1,579,146 $47 Million
Q1 2022

May 12, 2023
SELL
$23.07 - $27.99 $3.1 Million - $3.76 Million
-134,464 Reduced 7.92%
1,563,110 $41.1 Million
Q1 2022

May 09, 2022
SELL
$23.07 - $27.99 $60 Million - $72.8 Million
-2,599,310 Closed
0 $0
Q4 2021

Mar 09, 2022
BUY
$21.47 - $32.08 $55.8 Million - $83.4 Million
2,599,310 New
2,599,310 $60.5 Million
Q3 2021

Nov 14, 2022
BUY
$23.37 - $32.13 $35.8 Million - $49.2 Million
1,529,967 New
1,529,967 $47.2 Million
Q3 2021

Nov 05, 2021
SELL
$23.37 - $32.13 $41 Million - $56.4 Million
-1,756,435 Closed
0 $0
Q2 2021

Aug 15, 2022
BUY
$18.78 - $25.15 $33 Million - $44.2 Million
1,756,435 New
1,756,435 $43.1 Million
Q2 2021

Aug 10, 2021
SELL
$18.78 - $25.15 $31.4 Million - $42 Million
-1,671,885 Closed
0 $0
Q1 2021

May 09, 2022
BUY
$18.21 - $23.2 $30.4 Million - $38.8 Million
1,671,885 New
1,671,885 $31.2 Million
Q1 2021

May 07, 2021
SELL
$18.21 - $23.2 $34.4 Million - $43.8 Million
-1,889,117 Closed
0 $0
Q4 2020

Mar 02, 2021
BUY
$15.39 - $22.1 $29.1 Million - $41.7 Million
1,889,117 New
1,889,117 $37.7 Million
Q4 2020

Feb 10, 2021
SELL
$15.39 - $22.1 $31 Million - $44.5 Million
-2,015,117 Closed
0 $0
Q3 2020

Nov 12, 2021
BUY
$16.16 - $20.66 $32.6 Million - $41.6 Million
2,015,117 New
2,015,117 $33.4 Million
Q3 2020

Nov 10, 2020
SELL
$16.16 - $20.66 $32.6 Million - $41.7 Million
-2,020,062 Closed
0 $0
Q2 2020

Aug 13, 2021
BUY
$13.31 - $19.41 $26.9 Million - $39.2 Million
2,020,062 New
2,020,062 $39.2 Million
Q2 2020

Aug 07, 2020
SELL
$13.31 - $19.41 $21.6 Million - $31.4 Million
-1,619,921 Closed
0 $0
Q1 2020

May 07, 2021
BUY
$13.06 - $21.24 $21.2 Million - $34.4 Million
1,619,921 New
1,619,921 $23.4 Million
Q1 2020

May 08, 2020
SELL
$13.06 - $21.24 $21.2 Million - $34.4 Million
-1,619,921 Closed
0 $0
Q4 2019

Mar 03, 2020
BUY
$17.29 - $21.74 $28 Million - $35.2 Million
1,619,921 New
1,619,921 $33 Million
Q4 2019

Feb 12, 2020
SELL
$17.29 - $21.74 $25.8 Million - $32.5 Million
-1,493,495 Closed
0 $0
Q3 2019

Nov 13, 2020
BUY
$19.51 - $24.28 $29.1 Million - $36.3 Million
1,493,495 New
1,493,495 $29.1 Million
Q3 2019

Nov 08, 2019
SELL
$19.51 - $24.28 $23.6 Million - $29.4 Million
-1,210,156 Closed
0 $0
Q2 2019

Aug 13, 2020
BUY
$21.47 - $37.33 $26 Million - $45.2 Million
1,210,156 New
1,210,156 $27.3 Million
Q2 2019

Aug 09, 2019
SELL
$21.47 - $37.33 $25.8 Million - $44.9 Million
-1,203,401 Closed
0 $0
Q1 2019

May 11, 2020
BUY
$28.4 - $36.49 $3.72 Million - $4.78 Million
131,087 Added 12.22%
1,203,401 $43.9 Million
Q4 2018

Mar 04, 2019
BUY
$27.94 - $44.61 $30 Million - $47.8 Million
1,072,314 New
1,072,314 $31.6 Million
Q4 2018

Feb 08, 2019
SELL
$27.94 - $44.61 $30 Million - $47.8 Million
-1,072,314 Closed
0 $0
Q3 2018

Nov 12, 2019
BUY
$38.6 - $46.12 $41.4 Million - $49.5 Million
1,072,314 New
1,072,314 $45.5 Million
Q3 2018

Nov 09, 2018
SELL
$38.6 - $46.12 $42.3 Million - $50.5 Million
-1,095,738 Closed
0 $0
Q2 2018

Aug 12, 2019
BUY
$40.56 - $51.36 $44.4 Million - $56.3 Million
1,095,738 New
1,095,738 $45.1 Million
Q2 2018

Jul 23, 2018
SELL
$40.56 - $51.36 $44.4 Million - $56.3 Million
-1,095,738 Closed
0 $0
Q1 2018

May 15, 2019
BUY
$53.61 - $67.26 $58.7 Million - $73.7 Million
1,095,738 New
1,095,738 $63.5 Million
Q1 2018

May 09, 2018
SELL
$53.61 - $67.26 $39 Million - $49 Million
-728,027 Closed
0 $0
Q4 2017

Mar 05, 2018
BUY
$47.69 - $55.39 $34.7 Million - $40.3 Million
728,027 New
728,027 $39.8 Million
Q4 2017

Feb 09, 2018
SELL
$47.69 - $55.39 $32.3 Million - $37.5 Million
-677,678 Closed
0 $0
Q3 2017

Nov 13, 2018
BUY
$49.16 - $54.45 $33.3 Million - $36.9 Million
677,678 New
677,678 $34.5 Million
Q3 2017

Nov 07, 2017
SELL
$49.16 - $54.45 $35.7 Million - $39.5 Million
-726,192 Closed
0 $0
Q1 2017

May 11, 2018
SELL
N/A
-57,344 Reduced 7.32%
726,192 $42.5 Million
Q3 2016

Nov 13, 2017
BUY
N/A
783,536
783,536 $0

Others Institutions Holding ALKS

# of Institutions
394
Shares Held
176M
Call Options Held
558K
Put Options Held
427K
View Full List

About Alkermes plc.

ALKS Quotes by TradingView
  • Ticker ALKS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 164,254,000
  • Market Cap $4.49B
  • Description
  • Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...
More about ALKS
Track This Portfolio

Track Norges Bank Portfolio

Follow Norges Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Norges Bank, based on Form 13F filings with the SEC.

News

Stay updated on Norges Bank with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email